BRISBANE, CALIFORNIA, Aug. 03, 2023 (GLOBE NEWSWIRE) GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing.
GT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering Priced At Premium To Market - read this article along with other careers information, tips and advice on BioSpace